Jane Street Group LLC Takes Position in LifeVantage Co. (NASDAQ:LFVN)

Jane Street Group LLC purchased a new stake in shares of LifeVantage Co. (NASDAQ:LFVN) in the 4th quarter, Holdings Channel reports. The fund purchased 34,690 shares of the company’s stock, valued at approximately $608,000.

Several other institutional investors and hedge funds have also recently modified their holdings of LFVN. LPL Financial LLC raised its stake in shares of LifeVantage by 301.0% during the fourth quarter. LPL Financial LLC now owns 211,039 shares of the company’s stock valued at $3,700,000 after acquiring an additional 158,405 shares in the last quarter. EAM Investors LLC bought a new stake in shares of LifeVantage during the fourth quarter valued at approximately $1,056,000. Susquehanna International Group LLP raised its stake in shares of LifeVantage by 83.5% during the fourth quarter. Susquehanna International Group LLP now owns 128,082 shares of the company’s stock valued at $2,245,000 after acquiring an additional 58,279 shares in the last quarter. O Shaughnessy Asset Management LLC raised its stake in shares of LifeVantage by 56.2% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 93,576 shares of the company’s stock valued at $1,640,000 after acquiring an additional 33,658 shares in the last quarter. Finally, American Century Companies Inc. raised its stake in shares of LifeVantage by 50.5% during the fourth quarter. American Century Companies Inc. now owns 95,552 shares of the company’s stock valued at $1,675,000 after acquiring an additional 32,055 shares in the last quarter. Institutional investors own 35.32% of the company’s stock.

LifeVantage Stock Up 5.6%

Shares of NASDAQ:LFVN opened at $13.37 on Wednesday. The company has a market capitalization of $168.30 million, a price-to-earnings ratio of 23.88 and a beta of 0.41. LifeVantage Co. has a 52 week low of $5.22 and a 52 week high of $27.38. The firm has a 50 day moving average of $13.41 and a 200 day moving average of $16.28.

LifeVantage (NASDAQ:LFVN) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.10. The company had revenue of $58.44 million during the quarter, compared to the consensus estimate of $60.99 million. LifeVantage had a net margin of 3.46% and a return on equity of 34.29%.

LifeVantage Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 30th will be paid a $0.045 dividend. This is an increase from LifeVantage’s previous quarterly dividend of $0.04. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.18 dividend on an annualized basis and a yield of 1.35%. LifeVantage’s payout ratio is 26.09%.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.